美股市场个股详情

IPHA Innate Pharma

添加自选
  • 1.440
  • -0.225-13.51%
收盘价 11/15 16:00 (美东)
  • 1.440
  • 0.0000.00%
盘后 20:01 (美东)
1.17亿总市值-3257市盈率TTM

关于Innate Pharma公司

Innate Pharma SA是一家处于临床试验阶段的生物技术公司,致力于开发针对癌症患者的免疫治疗药物。其方法是通过治疗性抗体和专有平台ANKET(基于抗体的NK细胞接合疗法)来利用先天免疫系统。公司的收入来自于与制药公司签订的研究、合作和许可协议所获得的款项。其产品管线包括lacutamab、monalizumab、IPH5201、IPH5301、IPH6101、IPH62、IPH6401和IPH6501。

公司介绍

公司代码IPHA
公司名称Innate Pharma
上市日期2019/10/17
发行价格5.50
成立日期1999
CEODr. Mondher Mahjoubi, M.D.
所属市场纳斯达克
员工数量179
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址117, Avenue de Luminy
城市Marseille
省份普罗旺斯-阿尔卑斯-蓝色海岸
国家法国
邮编13009
电话33-4-30-30-30-30

董事高管

  • 姓名
  • 职务
  • 年薪
  • Dr. Mondher Mahjoubi, M.D.
  • Chairman of the Executive Board and Chief Executive Officer
  • --
  • Nicola Beltraminelli
  • Vice President and Chief Development Officer
  • --
  • Frederic Lombard
  • Chief Financial Officer
  • --
  • Eric Vivier, PhD
  • Senior Vice President and Chief Scientific Officer
  • --
  • Sonia Quaratino
  • Chief Medical Officer and Executive Vice President
  • --
  • Henry Wheeler
  • Vice President, Investor Relations and Communications
  • --
  • Claire de Saint Blanquat
  • Vice President, Legal and Corporate Affairs
  • --
  • Odile Belzunce
  • Vice President, Compliance, IT and Portfolio Management
  • --
  • Odile Laurent
  • Vice President, Human Resources
  • --
  • Yannis Morel, PhD
  • Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development
  • --
  • Irina Staatz-Granzer, PhD
  • Vice Chairman of the Supervisory Board
  • --
  • Herve Brailly, PhD
  • Chairman of the Supervisory Board
  • --
  • Sally Bennett
  • Member of the Supervisory Board
  • --
  • Pascale Boissel
  • Member of the Supervisory Board
  • --
  • Dr. Veronique Chabernaud, M.D.
  • Member of the Supervisory Board
  • --
  • Gilles Brisson
  • Member of the Supervisory Board
  • --
  • Olivier Martinez
  • Member of the Supervisory Board
  • --
  • Professor Jean-Yves Blay, PhD
  • Member of the Supervisory Board
  • --

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议
美股
综合热度
股票代码
最新价
涨跌幅

暂无数据